rs876659666
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The NM_002485.5(NBN):c.1397+1_1397+9delGTCTGTTTTinsACA variant causes a splice donor, splice region, intron change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002485.5 splice_donor, splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Aplastic anemia;C0023449:Acute lymphoid leukemia;C0398791:Microcephaly, normal intelligence and immunodeficiency Pathogenic:1
- -
Aplastic anemia Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1397+1_1397+9delGTCTGTTTTinsACA intronic variant, located downstream of coding exon 10 in the NBN gene, results from a deletion of 9 nucleotides and the insertion of 3 nucleotides at positions c.1397+1 to c.1397+9. This replaces the highly conserved canonical splice donor sequence in this region. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to abolish the native donor splice site; however, direct evidence is insufficient at this time (Ambry internal data). Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as likely pathogenic. -
Microcephaly, normal intelligence and immunodeficiency Uncertain:1
The NBN c.1397+1_1397+9delinsACA intronic change involves replacing nine nucleotides with three new nucleotides at the position 1397+1_1397+9 of intron 10 of the NBN gene. This variant is listed in ClinVar as likely pathogenic (SCV000276366.6), primarily based on in silico predictions. This variant is predicted to result in loss of the native splice donor site and abnormal gene splicing, resulting in nonsense-mediated decay or an abnormal protein product. To our knowledge, no functional studies have been performed to validate these predictions. Internal RNAseq data from the paired tumor sample compared to other similar tumor RNA data do not indicate an apparent abnormal splicing pattern although the assessment regarding potential intron retention is inconclusive. This variant is absent in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). To our knowledge, this variant has not been reported in individuals with Nijmegen breakage syndrome or NBN-associated cancers. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at